Company Profiles

driven by the PitchBook Platform

Solasia Pharma

Solasia Pharma
2006 FOUNDED
PUBLIC STATUS
11-50 EMPLOYEES
IPO LATEST DEAL TYPE
$28.5M TOTAL AMOUNT RAISED
Description

Developer of innovative drugs specializing in oncology area designed to improve the life of patients. The company's second candidate SP-02 or darinaparsin, is a mitochondrial-targeted agent for the treatment of various hematologic and solid cancers, while its third product is a medical device to treat pain associated with oral mucositis, enabling patients to minimize side effects caused by cancer treatment.

Formerly Known As
JapanBridge
Ownership Status
Publicly Held
Financing Status
Formerly VC-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Drug Discovery
Primary Office
Shiodome Building 3rd Floor
Shinagawa Building 1-2-20,Minato-ku
Tokyo, 105-0022
Japan

+81 (0)36 721 8520
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Solasia Pharma’s full profile, request a free trial.

Solasia Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 01-Mar-2017 $28.5M Completed Generating Revenue
6. Later Stage VC (Series D) 21-Aug-2015 000.00 000.00 Completed Generating Revenue
5. Later Stage VC 30-Sep-2013 0000 000.00 Completed Generating Revenue
4. Later Stage VC (Series B2) 18-Sep-2012 0000 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Apr-2009 000 000.00 Completed Startup
2. Early Stage VC (Series A2) 22-Sep-2007 $6.5M $7.8M Completed Startup
1. Early Stage VC (Series A) 06-Dec-2006 $1.3M $1.3M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Solasia Pharma Executive Team (7)

Name Title Board
Seat
Contact
Info
Yoshihiro Arai President, Representative Director & Board Member
Toshio Miyashita Chief Financial Officer, Board Member, Chief Manager & Director
Vivian Zhang General Manager
Koji Shinozaki Director, Business Development
Shigeru Sakamaki Director, Development
You’re viewing 5 of 7 executives. Get the full list »

Solasia Pharma Board Members (14)

Name Representing Role Since Contact
Info
Dave Preston Self Board Member 000 0000
Masahiro Michisuji Self Board Member 000 0000
Norikazu Eiki Solasia Pharma Board Member 000 0000
Stanley Lau Solasia Pharma Board Member 000 0000
Toshio Miyashita Solasia Pharma Chief Financial Officer, Board Member, Chief Manager & Director 000 0000

7 Former Board Members

You’re viewing 5 of 14 board members. Get the full list »